We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-15.16%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$1.05B
Cap. Flow
-$737M
Cap. Flow %
-52.65%
Top 10 Hldgs %
29.68%
Holding
181
New
76
Increased
18
Reduced
42
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 45.77%
2 Technology 31.94%
3 Communication Services 11.78%
4 Consumer Discretionary 2.11%
5 Industrials 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$459B
$15.7M 1.12%
+290,745
New +$17.2M
CHTR icon
27
Charter Communications
CHTR
$17.2B
$14.7M 1.05%
+33,664
New +$16.5M
KDMN
28
DELISTED
Kadmon Holdings, Inc.
KDMN
$14.5M 1.04%
3,471,350
+2,200,030
+173% +$9.47M
PRNB
29
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$14.4M 1.03%
+242,776
New +$14.2M
AAPL icon
30
Apple
AAPL
$4.46T
$13.7M 0.98%
+216,108
New +$15.9M
ZGNX
31
DELISTED
Zogenix, Inc.
ZGNX
$13.6M 0.97%
551,155
+367,168
+200% +$13.4M
MCK icon
32
McKesson
MCK
$96.8B
$13.4M 0.96%
+99,295
New +$14.5M
REGN icon
33
Regeneron Pharmaceuticals
REGN
$78.2B
$13.4M 0.96%
+27,477
New +$11.3M
COR icon
34
Cencora
COR
$60B
$12.9M 0.92%
+146,007
New +$12.9M
TMUS icon
35
T-Mobile US
TMUS
$190B
$12.2M 0.87%
+145,550
New +$12.3M
ICUI icon
36
ICU Medical
ICUI
$4.32B
$11.7M 0.83%
57,903
-4,668
-7% -$899K
DRNA
37
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.6M 0.83%
632,100
+260,232
+70% +$5.06M
BMRN icon
38
BioMarin Pharmaceuticals
BMRN
$11.6B
$11.3M 0.81%
134,149
-23,558
-15% -$2.03M
UNH icon
39
UnitedHealth
UNH
$377B
$11.2M 0.8%
+44,843
New +$12.3M
EW icon
40
Edwards Lifesciences
EW
$51.1B
$10.8M 0.77%
+172,383
New +$12.4M
VSH icon
41
Vishay Intertechnology
VSH
$5.43B
$10.7M 0.76%
+741,610
New +$14M
LYFT icon
42
Lyft
LYFT
$6.22B
$10.7M 0.76%
+396,892
New +$15.8M
PTCT icon
43
PTC Therapeutics
PTCT
$5.68B
$10.5M 0.75%
235,286
-81,940
-26% -$4.13M
VTRS icon
44
Viatris
VTRS
$20.5B
$10.4M 0.74%
+697,226
New +$13.4M
STM icon
45
STMicroelectronics
STM
$46.5B
$10.1M 0.72%
472,310
-239,420
-34% -$6.31M
SNX icon
46
TD Synnex
SNX
$20.3B
$9.71M 0.69%
265,688
-124,644
-32% -$7.64M
TFX icon
47
Teleflex
TFX
$6.18B
$9.6M 0.69%
32,780
+4,440
+16% +$1.55M
MOH icon
48
Molina Healthcare
MOH
$10.2B
$9.54M 0.68%
+68,276
New +$9.14M
ABT icon
49
Abbott
ABT
$185B
$9.52M 0.68%
+120,616
New +$10.1M
SMTC icon
50
Semtech
SMTC
$11.1B
$9.33M 0.67%
248,861
+150,226
+152% +$6.8M

Similar funds

Woodline Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Woodline Partners held 181 positions worth $1.4B, down 43% from $2.45B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodline Partners withdrew a net $737M in Q1 2020, closing 45 positions and reducing 42 holdings. Its most notable exit was Texas Instruments, an estimated $69.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Woodline Partners opened a new position in Pfizer worth $65.7M.

  • Woodline Partners's largest Q1 2020 buy was Pfizer: 2,120,811 shares worth $65.7M.
  • Woodline Partners added most to Immunomedics Inc in Q1 2020, an estimated $23M increase.
  • Woodline Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $61.4M.
  • Woodline Partners fully exited Texas Instruments in Q1 2020, selling an estimated $69.5M.
  • Woodline Partners's ten largest holdings make up 30% of its $1.4B portfolio in Q1 2020.
  • Woodline Partners opened 76 new positions and closed 45 in Q1 2020.
  • Woodline Partners's portfolio value fell 43% quarter-over-quarter to $1.4B.

Based on Woodline Partners's 13F filing for Q1 2020, filed 15 May 2020.